Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Regional Variation in Bladder Cancer Clinical Trial Availability in the US.
Journal: JAMA network open
Published: September 03, 2026
Real-World Efficacy and Safety of Belzutifan in Sporadic Metastatic Renal Cell Carcinoma.
Journal: Clinical genitourinary cancer
Published: April 22, 2026
Evaluating Worldwide Disparities in Bladder Cancer Clinical Trial Availability.
Journal: Cancers
Published: April 12, 2026
Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell Tumors.
Journal: Cancer research communications
Published: March 31, 2026
Germline Variants in Bladder and Upper Tract Urothelial Cancers: Prevalence and Clinical Context in a Large Testing Registry.
Journal: European urology open science
Published: February 11, 2026
Real-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the UNITE Database.
Journal: Clinical genitourinary cancer
Published: December 02, 2025
Emerging antibody-drug conjugates in metastatic castration-resistant prostate cancer.
Journal: Urologic oncology
Published: December 02, 2025
Multicenter Phase II Study of Olaparib and the ATR Inhibitor Ceralasertib in Metastatic Castration-Resistant Prostate Cancer (TRAP).
Journal: JCO precision oncology
Published: September 16, 2025
Immunotherapy in Renal Cell Carcinoma.
Journal: Cancer treatment and research
Published: August 23, 2025
Pathogenic Germline Variant Prevalence and Genetic Testing Outcomes in Patients With Urothelial Carcinoma.
Journal: Clinical genitourinary cancer
Published: July 29, 2025
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma.
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma.
Journal: Frontiers in oncology
Published: July 19, 2025
Last Updated: 09/26/2026